Clinical Trial Update: Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial of talactoferrin alfa in patients with severe sepsis has been suspended, with ongoing assessment of safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Talactoferrin Alfa (talactoferrin alfa)

Snippet

Sponsor: Agennix | Conditions: Severe Sepsis | Phase 2, Phase 3 | Status: SUSPENDED